Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis

Elisabetta Degasperi, Maria Paola Anolli, Mathias Jachs, Thomas Reiberger, Victor de Lédinghen, Sophie Métivier, Gianpiero D’Offizi, F. di Maria, Christoph Schramm, Hartmut Schmidt, Caroline Zöllner, Frank Tacke, Christopher Dietz-Fricke, Heiner Wedemeyer, Μargarita Papatheodoridi, George Papatheodoridis, Ivana Carey, Kosh Agarwal, Florian van Bömmel, Maurizia Rossana Brunetto, Mariana Cardoso, Gabriella Verucchi, Alessia Ciancio, Fabien Zoulim, Soo Aleman, Nasser Semmo, Alessandra Mangia, Marie‐Noëlle Hilleret, Uta Merle, Teresa Santantonio, Nicola Coppola, Adriano Pellicelli, Bruno Roche, Xavier Causse, Louis d’Altéroche, Jérôme Dumortier, Nathalie Ganne‐Carrié, Frédéric Heluwaert, Isabelle Ollivier‐Hourmand, Dominique Roulot, Mauro Viganò, Alessandro Loglio, Alessandro Federico, Francesca Pileri, Monia Maracci, Matteo Tonnini, Jean‐Pierre Arpurt, Karl Barange, Éric Billaud, Stanislas Pol, Anne Gervais, Anne Minello, Isabelle Rosa, Massimo Puoti, Pietro Lampertico